COF vs RNAC · P/E 62, rev $53.43B vs P/E 2.1, rev $38.9M
Capital One Financial Corporation (COF) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
COF currently screens at market cap $125.00B and trailing P/E 61.8. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the COF and RNAC stock pages for the full models.
Not investment advice.